OUR TEAM
Each partner brings a distinct lens—strategic positioning, transaction execution, commercial validation, and industrial scalability—ensuring that every mandate is evaluated and executed from multiple critical angles.
Recent Mandates
European synthetic biology CRO— sell-side advisory
U.S. precision fermentation CDMO platform— sell-side advisory
U.S. electronics coatings specialist— sell-side advisory
Chinese laboratory reagents leader — buy-side advisory (U.S.); buy-side acquisition program (EU)
Indian family investment group (life sciences) — buy-side advisory (EU)
LATAM pharmaceutical group — proprietary deal origination (Mexico target)
Canadian industrial chemicals platform — proprietary deal origination
Middle Eastern masterbatch producer — strategic advisory and M&A support
Canadian cleaning products formulator — proprietary deal origination
Bogdan Comanita, PhD MBA | Managing Partner
- Leads MarketChemica and coordinates execution across Life Sciences, Nutrition, Personal & Household Care, and Advanced Materials
- Advises on sell-side and buy-side transactions across value-added chemicals, biotechnology, and specialty materials
- Leads end-to-end M&A processes, including strategic positioning, deal marketing, buyer outreach, structuring, and negotiation
- Known for translating complex technical platforms into clear strategic equity stories, aligned with buyer-specific strategic fit
- Extensive experience coordinating cross-functional deal teams across financial, operational, and technical workstreams
- Cross-border focus with transatlantic execution and global outreach across North America, Europe, Asia, and LATAM
Ron Newman, PhD Chem Eng. | Partner
- Leads the Nutrition, Personal & Household Care vertical, advising on sell-side and buy-side transactions across ingredients, formulations, and specialty chemicals
- Strong track record in deal origination and execution, from opportunity sourcing through diligence and process coordination
- Known for assembling and leading multidisciplinary deal teams, integrating financial, technical, regulatory, environmental, and health & safety workstreams
- Extensive experience managing end-to-end transaction processes, ensuring alignment across stakeholders and maintaining execution discipline
- Deep expertise in formulation-driven businesses, enabling rigorous assessment of product portfolios, customer positioning, and scalability
- Combines technical depth with practical execution focus, bridging commercial reality with transaction positioning
Paul Vosejpka, PhD | Partner
- Leads the Advanced Materials vertical, advising on sell-side and buy-side transactions across specialty chemicals, materials, and industrial technologies
- Brings a strong corporate acquirer perspective from senior roles at Dow, with deep understanding of how strategics evaluate acquisitions and integration risk
- Plays a central role in transaction execution and process management, coordinating diligence, aligning stakeholders, and maintaining timeline discipline
- Known for keeping complex transactions on track and execution-focused, ensuring clarity, accountability, and momentum
- Deep expertise in materials, product development, and industrial scale-up, enabling rigorous assessment of assets, processes, and economic scalability
- Combines operating experience with hands-on M&A execution, bridging industrial reality with transaction decision-making
Julien Meissonnier, MSE MBA | Partner
- Focuses on sell-side and buy-side advisory in life sciences, including biotechnology, CDMOs, CROs, and medical technologies
- Actively involved across the full M&A process, including positioning, buyer outreach, structuring, negotiation, and execution
- Currently engaged in the sell-side advisory of a synthetic biology platform, integrating CRO and precision fermentation CDMO capabilities
- Buy-side advisor to an Indian family investment group pursuing life sciences acquisitions in Europe
- Brings experience in IPOs, private equity financings, and cross-border transactions, with capital raised exceeding $100M
- Combines M&A execution with first-hand experience as a founder, offering practical insight into scaling, financing, and exit dynamics
